CHONLUTEN is a peptide complex containing amino acids that help normalize the function of lung cells and the bronchial mucosa.
Clinical studies have established CHONLUTEN’s effectiveness in the comprehensive prevention and treatment of patients with lung and bronchial dysfunction associated with acute and chronic respiratory diseases of infectious and non-infectious origin, as well as in maintaining respiratory function in the elderly.
It was found that the use of CHONLUTEN in a course of treatment, in addition to conventional therapy in patients with respiratory failure and lung damage, improved well-being, reduced the frequency of coughing fits and asthma attacks, decreased the amount of sputum secreted, and increased physical performance. Positive changes were noted, including a decrease in wheezing and sputum secretion, reflecting a general trend toward a reduction in inflammatory manifestations of the disease.
CHONLUTEN can be taken not only as part of a comprehensive treatment plan but also as a preventative measure, for example, before the onset of acute respiratory infections and flu season.
CHONLUTEN is well tolerated by patients, with no reported side effects, complications, contraindications, or drug dependence.
The drug is not a medicinal product and is used in conjunction with other treatments.
Purpose:
- Prevention of respiratory diseases
- Age-related deterioration of the respiratory system
- Consequences of long-term smoking
- Intensive sports training
- Chronic respiratory failure
- Chronic cardiopulmonary failure
- Inflammatory pulmonary diseases (bronchitis, pneumonia, bronchial asthma)
- After prolonged use on a mechanical ventilator
- Inactive tuberculosis
- Chest trauma
- Respiratory tract burns
- Toxic damage to bronchopulmonary tissue, including exposure to carbon monoxide
Results:
Using CHONLUTEN in combination therapy leads to a reduction in the frequency of asthma attacks and morning coughing fits, a decrease in wheezing and sputum production, and an improvement in overall well-being and performance.
Prescribing CHONLUTEN in combination with immune-mediated medications reduces the risk of developing bronchopulmonary cancer.
The drug is effective not only for treating illnesses but also for improving lung capacity, lung capacity, and blood oxygenation in healthy individuals.
In athletes, using CHONLUTEN during competitions resulted in a significant increase in endurance compared to baseline values. Moreover, these high results were maintained until the end of the season.
Ingredients:
Peptide complex AC-7 (glycine, glutamic acid, aspartic acid), capsule shell (hydroxypropyl methyl cellulose, purified water, carrageenan, potassium acetate), flowing agent calcium salt of stearic acid.
Directions:
Adults: 1- 2 capsules, once or twice a day 30 minutes before meal, for 10-30 days. It is advised to repeat after 3-6 months.
After the course of CHONLUTEN it is recommended to take natural peptide for respiratory system TAXOREST (2 capsules 30 minutes before meal every morning during 1-2 months).
For chronic conditions, it is recommended to consult a physician before taking this medication.
Store in a dark place at a temperature below 25°C.
Contraindications:
Pregnancy and breastfeeding: Use after consultation with a physician.
The product has no side effects and does not cause drug dependence. It is used as a supplemental source of peptides.
Form release:
60 capsules of 0.215 g
Guaranteed authenticity and quality:
100% Original from Peptides – Scientific and Production Center of Revitalization and Health (Russian Federation)
Development and production:
TD Peptide Bio, St. Petersburg Institute of Bioregulation and Gerontology
Reviews
There are no reviews yet.